Grace Therapeutics, Inc. (GRCE)
Pharmaceutical Preparations
Latest Price
$2.08
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.99
P/B Ratio
0.52
Institutional Ownership
25.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Cerity Partners LLC | 849.1K | $3.0M | 5.14% | +426.3K | 2026-03-31 |
| Eversept Partners, LP | 756.6K | $3.0M | 4.58% | -- | 2026-03-31 |
| Nantahala Capital Management, LLC | 728.2K | $3.0M | 4.41% | -450.0K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 494.7K | $2.0M | 3.00% | +25 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 401.7K | $1.0M | 2.43% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 243.9K | $1.0M | 1.48% | +114.1K | 2026-03-31 |
| JANE STREET GROUP, LLC | 167.1K | -- | 1.01% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 98.7K | -- | 0.60% | +56.4K | 2026-03-31 |
| MARSHALL WACE, LLP | 91.4K | -- | 0.55% | -- | 2026-03-31 |
| Connective Capital Management, LLC | 84.5K | -- | 0.51% | -- | 2026-03-31 |